首页> 外国专利> STRAIN Francisella tularensis 15 / 23-1 ∆recA WITH REDUCED REACTOGENICITY TO CREATE A LIVING TULAREMIA VACCINE AND METHOD FOR ITS PRODUCTION

STRAIN Francisella tularensis 15 / 23-1 ∆recA WITH REDUCED REACTOGENICITY TO CREATE A LIVING TULAREMIA VACCINE AND METHOD FOR ITS PRODUCTION

机译:具有降低的反应活性以创建生活中的线粒体疫苗的菌株弗朗西斯菌tularensis 15 / 23-1ΔrecA及其生产方法

摘要

1. The strain Francisella tularensis 15 / 23-1ΔrecA with reduced reactogenicity to create a live tularemia vaccine, deposited in the State collection "GKPM-Obolensk", registration number B-6623.2. A method of obtaining a Francisella tularensis 15 / 23-1ΔrecA strain with reduced reactogenicity to create a live tularemia vaccine from the vaccine strain F. tularensis 15 NIIEG consists in sequential allelic exchange of one of two copies of the iglC gene and then the recA gene for their deleted variants using a suicide vector plasmid characterized in that the vector pGM5 constructed on the basis of the bireplicon plasmid pHV33 with the sacB gene introduced into it and deletion in the ori region of pC194, followed by the introduction of tularemia, is used as a suicide plasmid microbial transformation method.
机译:1.具有降低的反应原性的土拉弗朗西斯菌Tularensis 15 /23-1ΔrecA产生活的tularemia疫苗,保藏在国家藏品“ GKPM-Obolensk”中,注册号B-6623.2。从疫苗菌株F.tularensis 15 NIIEG获得具有降低的反应原性的土拉弗朗西斯菌15 /23-1ΔrecA菌株以制备活的tularemia疫苗的方法包括先将iglC基因的两个拷贝之一再进行recA基因的等位基因交换使用自杀载体质粒对其缺失的变体进行鉴定,其特征在于,使用在双复制子质粒pHV33的基础上构建的载体pGM5,其中引入了sacB基因,并在pC194的ori区域中缺失,随后引入了图莱血症。自杀质粒微生物转化方法。

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号